Subsequent Events	3 Months Ended
Nov. 30, 2016
Subsequent Events [Abstract]
Subsequent Events	NOTE 6 – SUBSEQUENT EVENTS On January 18, 2017, the Company entered into an employment agreement with an employee for the term until January 18, 2019 and a salary of $12,500 per month. In addition the Company issued 3,000,000 shares of restricted common stock at date of grant vesting at 350,000 shares every three months and the fair value of the shares will be evaluated during the second quarter 2017 review. In addition the employee is entitled to an additional 1,000,000 restricted common shares upon submission of Petlife INAD application for Vitalzul to the FDA and approval of application. The employee is entitled to an additional 3,000,000 restricted common shares upon final approval of Vitalzul by the FDA.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

No definition available.

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration